Rhythm (Nasdaq:IRTC) reported first-quarter financial results that came in ahead of the consensus forecast on Wall Street.

A new study from the Scripps Translational Science Institute, published in the American Journal of Medicine, shows that iRhythm's Zio patch, a wireless adhesive heart monitor patch, detects more ...

iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture ...

Two retrospective studies detected arrhythmias beyond 48 hours in 30% of patients post cardiac ablation and in 60% of ...

iRhythm's CFO, Daniel Wilson, discusses the company's expansion into the primary care arena. Wilson also mentions how a new form factor for the Zio patch is helping to facilitate the move in this ...

iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service. The ...

Rhythm Holdings, Inc (NASDAQ:IRTC) is among the best medical AI stocks to buy now. At the American College of Cardiology 2026 Annual Scientific Sessions on March 30, iRhythm shared analysis results ...

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC) (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) ...

iRhythm Technologies, Inc. has announced findings from the AVALON study, presented at HRS2025, highlighting the effectiveness of its Zio long-term continuous monitoring (LTCM) service in a younger, ...

New research presented at the Heart Rhythm Society’s 2026 meeting shows that 14-day continuous monitoring with iRhythm’s Zio patch detects significantly more atrial fibrillation recurrences than the ...